Cardinal Health Recalls Fenofibrate Capsules Due to Temperature Excursions
Cardinal Health Inc. is recalling 106 boxes of Fenofibrate capsules due to intermittent temperature excursions during storage.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity recall involving potential quality deviations.
Plain-English summary
Cardinal Health Inc. is recalling 106 boxes of Fenofibrate capsules, NDC 27241-118-04. The recall was initiated due to CGMP deviations involving intermittent exposure to temperature excursions during storage.
The affected product is a prescription medication distributed in Florida, Georgia, and South Carolina. The specific lot code for the recalled product is PA03410.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for guidance on obtaining a replacement.
The recalled product
- Product
- FENOFIBRATE (FENOFIBRATE)
- Brand
- FENOFIBRATE
- Manufacturer
- Cardinal Health Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 106
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- PA03410
UPCs (3)
- 0327241119040
- 0327241118043
- 0327241120046
Distribution
Part of a larger recall action
This product is one of 198 recalled by Cardinal Health Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 198 products in this recall →Related recalls
Same brand · FENOFIBRATE
- ModerateFenofibrate Capsules 200 mg Recalled for CGMP Manufacturing Deviations
FDA (Drugs) · 2026-07-01
- ModerateFenofibrate Capsules Recalled for CGMP Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModerateFenofibrate Tablets Recalled Due to Foreign Valacyclovir Tablet Presence
FDA (Drugs) · 2018-10-03
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30